Spotlight Session - Biologics

(B17) Comparison of biologic use in pivotal clinical trials vs. real-world setting with immune-mediated inflammatory diseases: an Italian population-based study from the VALORE project

(B18) Comparison of Serious Infections between Biosimilar and Bio-Originator Initiators in Canada: Population-Based Analyses

(B19) Disease severity profile and treatment switch patterns as treatment response proxy in Crohn’s disease population using Optum databases

(B20) Impact of COVID Lock-down on Adherence to Romosozumab Among US Post-menopausal Women Enrolled in Medicare

(B21) Joint pain in patients with atopic dermatitis receiving treatment with dupilumab in a nation-wide cohort study

(B23) Rates of Intraocular Inflammation Following Intravitreal Aflibercept Prefilled Syringe and Vial Injections in US Clinical Practice, 2014-2022

(B24) Risk of Venous Thromboembolism with Janus Kinase Inhibitors in Rheumatoid Arthritis: A Systematic Review